They can reduce the expression of tumor antigens, produce immune inhibitory molecules (such as PD-L1) [102], and recruit immunosuppressive cells (such as Treg cells) [92–94], thereby attenuating the cytotoxic capabilities of effector T cells. This evidence concerns the gene CD274 and neoplasm.